{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:25Z","timestamp":1791412525653,"version":"4.3.3"},"reference-count":108,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T00:00:00Z","timestamp":1660780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Candidiasis is a mycosis caused by opportunistic <jats:italic>Candida<\/jats:italic> species. The occurrence of fungal infections has considerably increased in the last few years primarily due to an increase in the number of immune-suppressed individuals. Alarming bloodstream infections due to <jats:italic>Candida<\/jats:italic> sp. are associated with a higher rate of morbidity and mortality, and are emerged as major healthcare concerns worldwide. Currently, chemotherapy is the sole available option for combating fungal diseases. Moreover, the emergence of resistance to these limited available anti-fungal drugs has further accentuated the concern and highlighted the need for early detection of fungal infections, identification of novel antifungal drug targets, and development of effective therapeutics and prophylactics. Thus, there is an increasing interest in developing safe and potent immune-based therapeutics to tackle fungal diseases. In this context, vaccine design and its development have a priority. Nonetheless, despite significant advances in immune and vaccine biology over time, a viable commercialized vaccine remains awaited against fungal infections. In this minireview, we enumerate various concerted efforts made till date towards the development of anti-<jats:italic>Candida<\/jats:italic> vaccines, an option with pan-fugal vaccine, vaccines in the clinical trial, challenges, and future opportunities.<\/jats:p>","DOI":"10.3389\/fcimb.2022.1002406","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T04:25:16Z","timestamp":1660796716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":40,"title":["Vaccines against candidiasis: Status, challenges and emerging opportunity"],"prefix":"10.3389","volume":"12","author":[{"given":"Satya Ranjan","family":"Sahu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swagata","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premlata","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abinash","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabasha Gyanadeep","family":"Utkalaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddheya Kumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narottam","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"B1","first-page":"12","article-title":"DNA Polymerase: A putative drug target against candidiasis","author":"Acharya","year":"2016","journal-title":"Front. Life Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/21505594.2022.2026037","article-title":"From environmental adaptation to host survival: Attributes that mediate pathogenicity of candida auris","volume":"13","author":"Allert","year":"2022","journal-title":"Virulence"},{"key":"B3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"Andre","year":"2008","journal-title":"Bull. World Health Organ"},{"key":"B4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13073-015-0245-0","article-title":"Immunoinformatics and epitope prediction in the age of genomic medicine","volume":"7","author":"Backert","year":"2015","journal-title":"Genome Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40265-019-01127-8","article-title":"Adverse effects associated with long-term administration of azole antifungal agents","volume":"79","author":"Benitez","year":"2019","journal-title":"Drugs"},{"key":"B6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0732-8893(93)90020-8","article-title":"Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis. disseminated versus single-organ infection","volume":"17","author":"Berenguer","year":"1993","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1128\/iai.51.2.668-674.1986","article-title":"Evidence for macrophage-mediated protection against lethal candida albicans infection","volume":"51","author":"Bistoni","year":"1986","journal-title":"Infection Immun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.15698\/mic2020.12.737","article-title":"Extracellular vesicles: An emerging platform in gram-positive bacteria","volume":"7","author":"Bose","year":"2020","journal-title":"Microbial Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1358\/dnp.2003.16.4.829331","article-title":"The role of antibodies against hsp90 in the treatment of fungal infections","volume":"16","author":"Burnie","year":"2003","journal-title":"Drug News Perspect."},{"key":"B11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/nature08064","article-title":"Evolution of pathogenicity and sexual reproduction in eight candida genomes","volume":"459","author":"Butler","year":"2009","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","article-title":"Saccharomyces cerevisiae as a vaccine against coccidioidomycosis","volume":"27","author":"Capilla","year":"2009","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1128\/IAI.67.2.826-833.1999","article-title":"Effectiveness of a vaccine composed of heat-killed candida albicans and a novel mucosal adjuvant, LT(R192G), against systemic candidiasis","volume":"67","author":"Cardenas-Freytag","year":"1999","journal-title":"Infection Immun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/mmy.40.3.291.299","article-title":"Partial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed candida albicans and the mucosal adjuvant LT(R192G)","volume":"40","author":"Cardenas-Freytag","year":"2002","journal-title":"Med. mycology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejpb.2014.11.028","article-title":"DODAB:monoolein liposomes containing candida albicans cell wall surface proteins: a novel adjuvant and delivery system","volume":"89","author":"Carneiro","year":"2015","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.actbio.2016.05.001","article-title":"Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis","volume":"39","author":"Carneiro","year":"2016","journal-title":"Acta biomaterialia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1473-3099(08)70016-1","article-title":"Fungal vaccines: real progress from real challenges","volume":"8","author":"Cassone","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1128\/MMBR.62.1.130-180","article-title":"Cell wall and secreted proteins of Candida albicans: identification, function, and expression","volume":"62","author":"Chaffin","year":"1998","journal-title":"Microbiology and molecular biology reviews"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1086\/657417","article-title":"Hyr1 protein and beta-glucan conjugates as anti-candida vaccines","volume":"202","author":"Cassone","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.mib.2012.04.004","article-title":"Recent progress in vaccines against fungal diseases","volume":"15","author":"Cassone","year":"2012","journal-title":"Curr. Opin. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","article-title":"A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models","volume":"30","author":"De Bernardis","year":"2012","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1128\/IAI.70.5.2725-2729.2002","article-title":"Intravaginal and intranasal immunizations are equally effective in inducing vaginal antibodies and conferring protection against vaginal candidiasis","volume":"70","author":"De Bernardis","year":"2002","journal-title":"Infection Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0264-410X(95)00256-Z","article-title":"Preclinical efficacy of a glucuronoxylomannan-tetanus toxoid conjugate vaccine of cryptococcus neoformans in a murine model","volume":"14","author":"Devi","year":"1996","journal-title":"Vaccine"},{"key":"B24","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining b-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Dziadek","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"B25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0264-410X(96)00137-5","article-title":"Liposomes containing candida albicans ribosomes as a prophylactic vaccine against disseminated candidiasis in mice","volume":"15","author":"Eckstein","year":"1997","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cid\/ciy185","article-title":"A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-a phase 2 randomized, double-blind, placebo-controlled trial","volume":"66","author":"Edwards","year":"2018","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. America"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/pmic.200300678","article-title":"Contribution of the antibodies response induced by a low virulent candida albicans strain in protection against systemic candidiasis","volume":"4","author":"Fernandez-Arenas","year":"2004","journal-title":"Proteomics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00662","article-title":"The evolution of drug resistance in clinical isolates of candida albicans","volume":"4","author":"Ford","year":"2015","journal-title":"eLife"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00747-19","article-title":"Fungal extracellular vesicles as potential targets for immune interventions","volume":"4","author":"Freitas","year":"2019","journal-title":"mSphere"},{"key":"B30","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/QCO.0b013e32835fb920","article-title":"Pathogenesis of invasive fungal infections","volume":"26","author":"Garcia-Vidal","year":"2013","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1128\/iai.63.7.2714-2719.1995","article-title":"Antibody response that protects against disseminated candidiasis","volume":"63","author":"Han","year":"1995","journal-title":"Infection Immun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1128\/IAI.66.12.5771-5776.1998","article-title":"A vaccine and monoclonal antibodies that enhance mouse resistance to candida albicans vaginal infection","volume":"66","author":"Han","year":"1998","journal-title":"Infection Immun."},{"key":"B33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1128\/microbiolspec.FUNK-0052-2016","article-title":"Fungal diversity revisited: 2.2 to 3.8 million species","volume":"5","author":"Hawksworth","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00280","article-title":"Candida albicans agglutinin-like sequence (Als) family vignettes: A review of als protein structure and function","volume":"7","author":"Hoyer","year":"2016","journal-title":"Front. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/IAI.74.5.3039-3041.2006","article-title":"The anti-candida vaccine based on the recombinant n-terminal domain of Als1p is broadly active against disseminated candidiasis","volume":"74","author":"Ibrahim","year":"2006","journal-title":"Infection Immun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"17120","DOI":"10.1038\/nmicrobiol.2017.120","article-title":"Stop neglecting fungi","volume":"2","author":"Jermy","year":"2017","journal-title":"Nat. Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc. Natl. Acad. Sci. United States America"},{"key":"B39","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-Induced trained immunity in NK cells: Role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s11095-014-1516-y","article-title":"Molecular adjuvants based on nonpyrogenic lipophilic derivatives of norAbuMDP\/GMDP formulated in nanoliposomes: stimulation of innate and adaptive immunity","volume":"32","author":"Knotigova","year":"2015","journal-title":"Pharm. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/0976500X20130201","article-title":"Caspofungin-induced fatal complete heart block: Another manifestation of kounis syndrome","volume":"4","author":"Kounis","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9778","DOI":"10.1128\/JVI.00355-11","article-title":"Mechanisms controlling virulence thresholds of mixed viral populations","volume":"85","author":"Lancaster","year":"2011","journal-title":"J. Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","article-title":"Antifungal drug resistance: Molecular mechanisms in candida albicans and beyond","volume":"121","author":"Lee","year":"2021","journal-title":"Chem. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s13311-016-0453-3","article-title":"Vaccinations for neuroinfectious disease: A global health priority","volume":"13","author":"Leibovitch","year":"2016","journal-title":"Neurotherapeutics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ejmech.2019.04.001","article-title":"Synthesis and immunological studies of beta-1,2-mannan-peptide conjugates as antifungal vaccines","volume":"173","author":"Liao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1-Th17 cells mediate protective adaptive immunity against staphylococcus aureus and candida albicans infection in mice","volume":"5","author":"Lin","year":"2009","journal-title":"PLoS Pathog."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","article-title":"Saccharomyces as a vaccine against systemic aspergillosis: 'the friend of man' a friend again","volume":"60","author":"Liu","year":"2011","journal-title":"J. Med. Microbiol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/j.vaccine.2010.12.119","article-title":"Immune responses induced by heat killed saccharomyces cerevisiae: a vaccine against fungal infection","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3109\/08820139.2012.692418","article-title":"Saccharomyces as a vaccine against systemic candidiasis","volume":"41","author":"Liu","year":"2012","journal-title":"Immunol. Invest."},{"key":"B50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijbiomac.2021.01.105","article-title":"Chitosan hydrogel loaded with recombinant protein containing epitope c from HSP90 of candida albicans induces protective immune responses against systemic candidiasis","volume":"173","author":"Li","year":"2021","journal-title":"Int. J. Biol. macromolecules"},{"key":"B51","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","article-title":"Nonfilamentous c. albicans mutants are avirulent","volume":"90","author":"Lo","year":"1997","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025909","article-title":"Active and passive immunization with rHyr1p-n protects mice against hematogenously disseminated candidiasis","volume":"6","author":"Luo","year":"2011","journal-title":"PLoS One"},{"key":"B53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. America"},{"key":"B54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/mmi.14004","article-title":"TLS Dependent and independent functions of DNA polymerase eta (Poleta\/Rad30) from pathogenic yeast candida albicans","volume":"110","author":"Manohar","year":"2018","journal-title":"Mol. Microbiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. America"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.612269","article-title":"A combination of polybacterial MV140 and candida albicans V132 as a potential novel trained immunity-based vaccine for genitourinary tract infections","volume":"11","author":"Martin-Cruz","year":"2020","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1128\/CMR.11.1.121","article-title":"Serologic response to cell wall mannoproteins and proteins of Candida albicans","volume":"11","author":"Marti\u00ednez","year":"1998","journal-title":"Clinical microbiology reviews"},{"key":"B58","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/mmy\/myt025","article-title":"Potential role of candida albicans germ tube antibody in the diagnosis of deep-seated candidemia","volume":"52","author":"Martinez-Jimenez","year":"2014","journal-title":"Med. mycology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1002\/pmic.200701056","article-title":"Immunoproteomic analysis of the protective response obtained from vaccination with candida albicans ecm33 cell wall mutant in mice","volume":"8","author":"Martinez-Lopez","year":"2008","journal-title":"Proteomics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jconrel.2011.01.016","article-title":"Metallochelating liposomes with associated lipophilised norAbuMDP as biocompatible platform for construction of vaccines with recombinant his-tagged antigens: preparation, structural study and immune response towards rHsp90","volume":"151","author":"Masek","year":"2011","journal-title":"J. Control Release"},{"key":"B61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1574-6968.1989.tb03413.x","article-title":"Cloning of a DNA sequence encoding a major fragment of the 47 kilodalton stress protein homologue of candida albicans","volume":"51","author":"Matthews","year":"1989","journal-title":"FEMS Microbiol. Lett."},{"key":"B62","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1128\/jcm.25.2.230-237.1987","article-title":"Isolation of immunodominant antigens from sera of patients with systemic candidiasis and characterization of serological response to candida albicans","volume":"25","author":"Matthews","year":"1987","journal-title":"J. Clin. Microbiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1128\/AAC.47.7.2208-2216.2003","article-title":"Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90","volume":"47","author":"Matthews","year":"2003","journal-title":"Antimicrobial Agents chemotherapy"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1016\/j.vaccine.2021.04.031","article-title":"Safety, immunogenicity, and efficacy of NDV-3A against staphylococcus aureus colonization: A phase 2 vaccine trial among US army infantry trainees","volume":"39","author":"Millar","year":"2021","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans secreted aspartyl proteinases in virulence and pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13103","article-title":"Virulence and pathogenicity of a candida albicans mutant with reduced filamentation","volume":"21","author":"Peroumal","year":"2019","journal-title":"Cell. Microbiol."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1101\/2022.03.23.485455","article-title":"Commensal fungi candida albicans modulates dietary high-fat induced alterations in metabolism, immunity, and gut microbiota","author":"Peroumal","year":"2022","journal-title":"bioRxiv"},{"key":"B69","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.0818-9641.2004.01272.x","article-title":"Vaccine adjuvants: current state and future trends","volume":"82","author":"Petrovsky","year":"2004","journal-title":"Immunol. Cell Biol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","article-title":"A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique","volume":"28","author":"Pietrella","year":"2010","journal-title":"Vaccine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/13693780701883508","article-title":"Systemic and mucosal immunization with candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis","volume":"46","author":"Raska","year":"2008","journal-title":"Med. mycology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner And the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc. (Bayl Univ Med. Cent)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00346","article-title":"Extracellular vesicles in fungi: Past, present, and future perspectives","volume":"10","author":"Rizzo","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2217\/fmb.11.112","article-title":"Vesicular transport systems in fungi","volume":"6","author":"Rodrigues","year":"2011","journal-title":"Future Microbiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1038\/s41467-018-07738-1","article-title":"Single human b cell-derived monoclonal anti-candida antibodies enhance phagocytosis and protect against disseminated candidiasis","volume":"9","author":"Rudkin","year":"2018","journal-title":"Nat. Commun."},{"key":"B76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1128\/CMR.00056-09","article-title":"Clinical and laboratory update on blastomycosis","volume":"23","author":"Saccente","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1574-695X.2011.00802.x","article-title":"A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of candida albicans as a mucosal anticandidal vaccine","volume":"62","author":"Sandini","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"a019711","DOI":"10.1101\/cshperspect.a019711","article-title":"Fungal vaccines and immunotherapeutics","volume":"4","author":"Santos","year":"2014","journal-title":"Cold Spring Harbor Perspect. Med."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taab051","article-title":"Inactivated COVID-19 vaccine BBV152\/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2","volume":"28","author":"Sapkal","year":"2021","journal-title":"J. Travel Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CVI.00480-08","article-title":"Efficacy of a genetically engineered candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis","volume":"16","author":"Saville","year":"2009","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"B81","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","article-title":"NDV-3, a recombinant alum-adjuvanted vaccine for candida and staphylococcus aureus, is safe and immunogenic in healthy adults","volume":"30","author":"Schmidt","year":"2012","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1099\/00222615-39-4-241","article-title":"Synthetic peptide vaccines","volume":"39","author":"Sesardic","year":"1993","journal-title":"J. Med. Microbiol."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.01648","article-title":"Dectin-1 facilitates IL-18 production for the generation of protective antibodies against candida albicans","volume":"11","author":"Shen","year":"2020","journal-title":"Front. Microbiol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00312-2","article-title":"Vaccination with secreted aspartyl proteinase 2 protein from candida parapsilosis can enhance survival of mice during c. tropicalis-mediated systemic candidiasis","volume":"88","author":"Shukla","year":"2020","journal-title":"Infection Immun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3797\/scipharm.1404-07","article-title":"Oral immunization against candidiasis using Lactobacillus casei displaying enolase 1 from Candida albicans","volume":"82","author":"Shibasaki","year":"2014","journal-title":"Scientia Pharmaceutica"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007460","article-title":"The NDV-3A vaccine protects mice from multidrug resistant candida auris infection","volume":"15","author":"Singh","year":"2019","journal-title":"PLoS Pathog."},{"key":"B87","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1086\/499057","article-title":"Current treatment strategies for disseminated candidiasis","volume":"42","author":"Spellberg","year":"2006","journal-title":"Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. America"},{"key":"B88","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1086\/504691","article-title":"Efficacy of the anti-candida rAls3p-n or rAls1p-n vaccines against disseminated and mucosal candidiasis","volume":"194","author":"Spellberg","year":"2006","journal-title":"J. Infect. Dis."},{"key":"B89","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.1128\/IAI.73.9.6191-6193.2005","article-title":"The anti-candida albicans vaccine composed of the recombinant n terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice","volume":"73","author":"Spellberg","year":"2005","journal-title":"Infection Immun."},{"key":"B90","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1128\/IAI.00700-08","article-title":"The antifungal vaccine derived from the recombinant n terminus of Als3p protects mice against the bacterium staphylococcus aureus","volume":"76","author":"Spellberg","year":"2008","journal-title":"Infection Immun."},{"key":"B91","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.3109\/13693786.2010.497775","article-title":"Developing a vaccine against aspergillosis","author":"Stevens","year":"2011","journal-title":"Med. mycology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/s41598-020-57906-x","article-title":"In silico design of a multivalent vaccine against candida albicans","volume":"10","author":"Tarang","year":"2020","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1002\/pmic.200600321","article-title":"A proteomic-based approach for the identification of candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis","volume":"6","author":"Thomas","year":"2006","journal-title":"Proteomics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis","volume":"15","author":"Thornton","year":"2008","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"B95","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","article-title":"A novel glyco-conjugate vaccine against fungal pathogens","volume":"202","author":"Torosantucci","year":"2005","journal-title":"J. Exp. Med."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00897","article-title":"The elusive anti-candida vaccine: Lessons from the past and opportunities for the future","volume":"9","author":"Tso","year":"2018","journal-title":"Front. Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-3083.1992.tb03132.x","article-title":"The role of BCG\/PPD-activated macrophages in resistance against systemic candidiasis in mice","volume":"36","author":"van 't Wout","year":"1992","journal-title":"Scandinavian J. Immunol."},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13238","article-title":"Protective effect of fungal extracellular vesicles against murine candidiasis","volume":"22","author":"Vargas","year":"2020","journal-title":"Cell. Microbiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.2147\/IJN.S93105","article-title":"Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy","volume":"11","author":"Voltan","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"B100","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4161\/21505594.2014.983015","article-title":"Vaccines in the treatment of invasive candidiasis","volume":"6","author":"Wang","year":"2015","journal-title":"Virulence"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02145-19","article-title":"A heat-killed cryptococcus mutant strain induces host protection against multiple invasive mycoses in a murine vaccine model","volume":"10","author":"Wang","year":"2019","journal-title":"mBio"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1002\/eji.201545591","article-title":"Fonsecaea pedrosoi-induced Th17-cell differentiation in mice is fostered by dectin-2 and suppressed by mincle recognition","volume":"45","author":"Wuthrich","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.vaccine.2015.11.035","article-title":"Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis","volume":"34","author":"Xin","year":"2016","journal-title":"Vaccine"},{"key":"B104","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1128\/IAI.00234-06","article-title":"Hybridoma passage in vitro may result in reduced ability of antimannan antibody to protect against disseminated candidiasis","volume":"74","author":"Xin","year":"2006","journal-title":"Infection and immunity"},{"key":"B105","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining \u03b2-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"Xin","year":"2008","journal-title":"P.  Nat. Acad. of Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035106","article-title":"Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis","volume":"7","author":"Xin","year":"2012","journal-title":"PLoS One"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.vaccine.2019.03.061","article-title":"Design of a mimotope-peptide based double epitope vaccine against disseminated candidiasis","volume":"37","author":"Xin","year":"2019","journal-title":"Vaccine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mycres.2008.11.016","article-title":"Non-lethal candida albicans cph1\/cph1 efg1\/efg1 mutant partially protects mice from systemic infections by lethal wild-type cells","volume":"113","author":"Yang","year":"2009","journal-title":"Mycol Res."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1002406\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T04:25:20Z","timestamp":1660796720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1002406\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":108,"alternative-id":["10.3389\/fcimb.2022.1002406"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1002406","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]},"article-number":"1002406"}}